TKNO 5.01 (+5.03%)
US02080L1026Drug ManufacturersDrug Manufacturers - Specialty & Generic

Alpha Teknova (TKNO) Stock Highlights

5.01 | +5.03%
2024-09-19 05:13:33
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification.

Statistics

Range Today
4.72 5.07
Volume Today 119.4K
Range 1 Year
1.15 5.45
Volume 1 Year 47.9M
Range 3 Year
1.15 28
Volume 3 Year 77.29M
Range 10 Year
1.15 30.89
Volume 10 Year 89.93M

Highlights

Market Capitalization 234.53M (small)
Floating Shares 8.97M
Current Price 5.01
Price To Earnings -4.96
Price To Revenue 7.31
Price To Book 2.27
Earnings Per Share -0.92
Payout Ratio 0%

Performance

Latest +5.03%
1 Month -0.79%
3 Months +194.71%
6 Months +74.56%
1 Year +186.29%
3 Years -79.06%
5 Years -75.82%
10 Years -75.82%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.